These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 38012711)

  • 1. Inhibition of Dickkopf-1 enhances the anti-tumor efficacy of sorafenib via inhibition of the PI3K/Akt and Wnt/β-catenin pathways in hepatocellular carcinoma.
    Seo SH; Cho KJ; Park HJ; Lee HW; Kim BK; Park JY; Kim DY; Ahn SH; Cheon JH; Yook JI; Kim MD; Joo DJ; Kim SU
    Cell Commun Signal; 2023 Nov; 21(1):339. PubMed ID: 38012711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD58 acts as a tumor promotor in hepatocellular carcinoma via activating the AKT/GSK-3β/β-catenin pathway.
    Wang C; Cao F; Cao J; Jiao Z; You Y; Xiong Y; Zhao W; Wang X
    J Transl Med; 2023 Aug; 21(1):539. PubMed ID: 37573318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical exercise suppresses hepatocellular carcinoma progression by alleviating hypoxia and attenuating cancer stemness through the Akt/GSK-3β/β-catenin pathway.
    Xiao CL; Zhong ZP; Lü C; Guo BJ; Chen JJ; Zhao T; Yin ZF; Li B
    J Integr Med; 2023 Mar; 21(2):184-193. PubMed ID: 36781361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erinacine Facilitates the Opening of the Mitochondrial Permeability Transition Pore Through the Inhibition of the PI3K/ Akt/GSK-3β Signaling Pathway in Human Hepatocellular Carcinoma.
    Zhou LJ; Mo YB; Bu X; Wang JJ; Bai J; Zhang JW; Cheng AB; Ma JH; Wang YW; Xie YX
    Cell Physiol Biochem; 2018; 50(3):851-867. PubMed ID: 30355923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway.
    Xie L; Li M; Liu D; Wang X; Wang P; Dai H; Yang W; Liu W; Hu X; Zhao M
    Molecules; 2019 Jan; 24(3):. PubMed ID: 30678274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DUXAP10 inhibition attenuates the proliferation and metastasis of hepatocellular carcinoma cells by regulation of the Wnt/β-catenin and PI3K/Akt signaling pathways.
    Han K; Li C; Zhang X; Shang L
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30996112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel mechanism of hepatocellular carcinoma cell apoptosis induced by lupeol via Brain-Derived Neurotrophic Factor Inhibition and Glycogen Synthase Kinase 3 beta reactivation.
    Zhang L; Tu Y; He W; Peng Y; Qiu Z
    Eur J Pharmacol; 2015 Sep; 762():55-62. PubMed ID: 26004524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma.
    Toh TB; Lim JJ; Hooi L; Rashid MBMA; Chow EK
    J Hepatol; 2020 Jan; 72(1):104-118. PubMed ID: 31541681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PDCD6 Promotes Hepatocellular Carcinoma Cell Proliferation and Metastasis through the AKT/GSK3β/β-catenin Pathway.
    Wen SY; Liu YT; Wei BY; Ma JQ; Chen YY
    Biomed Environ Sci; 2023 Mar; 36(3):241-252. PubMed ID: 37005078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APLN promotes hepatocellular carcinoma through activating PI3K/Akt pathway and is a druggable target.
    Chen H; Wong CC; Liu D; Go MYY; Wu B; Peng S; Kuang M; Wong N; Yu J
    Theranostics; 2019; 9(18):5246-5260. PubMed ID: 31410213
    [No Abstract]   [Full Text] [Related]  

  • 11. A novel multitarget kinase inhibitor BZG with potent anticancer activity in vitro and vivo enhances efficacy of sorafenib through PI3K pathways in hepatocellular carcinoma cells.
    Wang L; Zhan Y; Wu Z; Lin M; Jin X; Jiang L; Qiu Y
    Biomed Pharmacother; 2020 May; 125():110033. PubMed ID: 32187962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nek2 augments sorafenib resistance by regulating the ubiquitination and localization of β-catenin in hepatocellular carcinoma.
    Deng L; Sun J; Chen X; Liu L; Wu D
    J Exp Clin Cancer Res; 2019 Jul; 38(1):316. PubMed ID: 31319849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulated PLAC8 promotes hepatocellular carcinoma cell proliferation by enhancing PI3K/Akt/GSK3β/Wnt/β-catenin signaling.
    Zou L; Chai J; Gao Y; Guan J; Liu Q; Du JJ
    Biomed Pharmacother; 2016 Dec; 84():139-146. PubMed ID: 27643556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADORA1 promotes nasopharyngeal carcinoma cell progression through regulation of PI3K/AKT/GSK-3β/β-catenin signaling.
    Pan S; Liang S; Wang X
    Life Sci; 2021 Aug; 278():119581. PubMed ID: 33961854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NCSTN promotes hepatocellular carcinoma cell growth and metastasis via β-catenin activation in a Notch1/AKT dependent manner.
    Li H; Lan T; Xu L; Liu H; Wang J; Li J; Chen X; Huang J; Li X; Yuan K; Zeng Y; Wu H
    J Exp Clin Cancer Res; 2020 Jul; 39(1):128. PubMed ID: 32631394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EPHB2 Activates β-Catenin to Enhance Cancer Stem Cell Properties and Drive Sorafenib Resistance in Hepatocellular Carcinoma.
    Leung HW; Leung CON; Lau EY; Chung KPS; Mok EH; Lei MML; Leung RWH; Tong M; Keng VW; Ma C; Zhao Q; Ng IOL; Ma S; Lee TK
    Cancer Res; 2021 Jun; 81(12):3229-3240. PubMed ID: 33903122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Y-box binding protein 1 augments sorafenib resistance
    Liu T; Xie XL; Zhou X; Chen SX; Wang YJ; Shi LP; Chen SJ; Wang YJ; Wang SL; Zhang JN; Dou SY; Jiang XY; Cui RL; Jiang HQ
    World J Gastroenterol; 2021 Jul; 27(28):4667-4686. PubMed ID: 34366628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretory clusterin promotes hepatocellular carcinoma progression by facilitating cancer stem cell properties via AKT/GSK-3β/β-catenin axis.
    Zheng W; Yao M; Wu M; Yang J; Yao D; Wang L
    J Transl Med; 2020 Feb; 18(1):81. PubMed ID: 32059741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emodin inhibits invasion and migration of hepatocellular carcinoma cells via regulating autophagy-mediated degradation of snail and β-catenin.
    Qin B; Zeng Z; Xu J; Shangwen J; Ye ZJ; Wang S; Wu Y; Peng G; Wang Q; Gu W; Tang Y
    BMC Cancer; 2022 Jun; 22(1):671. PubMed ID: 35715752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing of lemur tyrosine kinase 2 restricts the proliferation and invasion of hepatocellular carcinoma through modulation of GSK-3β/Wnt/β-catenin signaling.
    Zhao G; Song Y; Dong L; Shi H; Li H; Yang L; Wang J
    Biochem Biophys Res Commun; 2019 Oct; 517(4):722-728. PubMed ID: 31395338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.